Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
basket, certification, comparison, Connecticut, Flaim, flu, HHS, Horizon, prohibited, Radcliffe, repaid
Filing tables
Filing exhibits
Related press release
Associated CVS transcripts
CVS similar filings
Filing view
External links
Exhibit 15.1
Letter re: Unaudited Interim Financial Information
November 6, 2020
To the Shareholders and the Board of Directors of CVS Health Corporation
We are aware of the incorporation by reference in the Registration Statements (Form S-3ASR No. 333-238506 and Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation of our report dated November 6, 2020, relating to the unaudited condensed consolidated interim financial statements of CVS Health Corporation that is included in its Form 10-Q for the quarter ended September 30, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts